1 for 40 RS will leave this worthless at this price. Wait till after split IMO.
You can gamble before the Aug 22nd dt though.
--------------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
þ Preliminary Proxy Statement
o Confidential, For Use of the Commission Only (As Permitted by Rule 14a-6(e)(2))
o Definitive Proxy Statement
o Definitive Additional Materials
o Soliciting Material under Rule 14a-12
PURAMED BIOSCIENCE, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ No fee required
o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
o Fee paid previously with preliminary materials.
o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing.
(1) Amount Previously Paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
July 29, 2014
TO OUR SHAREHOLDERS:
Our Board of Directors has called and invites you to attend a Special Meeting of Shareholders of PuraMed Bioscience, Inc. (together with any subsidiaries, the “Company”, “PuraMed”, “we”, “us” or “our”). This meeting will be held on August 22, 2014 at 1:00 p.m. Central Time at the Company’s headquarters located at 1326 Schofield Avenue, Schofield, Wisconsin 54476.
At this meeting, you will be asked to authorize our Board of Directors to:
(1) Authorize the change in domicile of PuraMed Bioscience, Inc. from Minnesota to Nevada
(2) To effect a 1-for-40 reverse split of the outstanding common stock of PuraMed Bioscience, Inc.
The enclosed Notice of Special Meeting of Shareholders and Proxy Statement contain details about the business to be conducted at the meeting. To ensure that your shares are represented at the meeting, we urge you to mark your choice on the enclosed proxy card, sign and date the card and return it promptly in the envelope provided.
Even if you plan to attend the meeting, you are requested to sign, date and return the proxy card in the enclosed envelope. If you attend the meeting after having returned the enclosed proxy card, you may revoke your proxy, if you wish, and vote in person. If you would like to attend and your shares are not registered in your own name, please ask the broker, trust, bank or other nominee that holds the shares to provide you with evidence of your share ownership.
Thank you for your support.
Sincerely,
/s/ Russell W. Mitchell
Russell W. Mitchell
Chief Executive Officer
July 29, 2014
Schofield, Wisconsin
--------------------------------------------------------------------------------
PURAMED BIOSCIENCE, INC.
1326 Schofield Avenue
Schofield, Wisconsin 54476
(715) 359-6373
NOTICE OF SPECIAL
MEETING OF SHAREHOLDERS
TO BE HELD
AUGUST 22, 2014
To Our Shareholders:
PuraMed Bioscience, Inc. (the “Company”) will hold a Special Meeting of Shareholders at the Company’s headquarters located at 1326 Schofield Avenue, Schofield, Wisconsin 54476 on August 22, 2014, for the following purposes:
(1) Authorize the change in domicile of PuraMed Bioscience, Inc. from Minnesota to Nevada (the “Nevada Domestication”)
(2) To effect a 1-for-40 reverse split of the outstanding common stock of PuraMed Bioscience, Inc. (the “Stock Split”)
The holders of record of the Company’s Common Stock at the close of business on July 24, 2014 are entitled to notice of and to vote at the Special Meeting with respect to the Nevada Domestication and the Stock Split. The holders of record of at least a majority of the shares of Common Stock of the Company entitled to vote must be present in person or represented by proxy in order to hold the Special Meeting. Accordingly, it is important that your shares be represented at the meeting. Whether or not you plan to attend the Special Meeting, please complete the enclosed proxy card and sign, date and return it promptly in the enclosed postage-paid envelope. If you do plan to attend the Special Meeting in person, you may withdraw your proxy and vote personally on all matters brought before the Special Meeting. The Board of Directors recommends that you vote FOR the Nevada Domestication. This matter is more fully described in the Proxy Statement accompanying this Notice.
